drugset / Trial / NCT02786810
Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy
NaSingle-groupOpen-labelDiagnostic
Summary
The study will be evaluating the efficacy and safety of a contrast drug in pediatric renal ultrasound.
Timeline
- Start
- 2016-03
- Primary completion
- 2016-11
- Completion
- 2016-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lumason | Diagnostic / imaging agent | 0.03 unknown | Intravenous |